113 related articles for article (PubMed ID: 25047684)
1. HBV preS2 transactivates FOXP3 expression in malignant hepatocytes.
Zhang X; Gao L; Liang X; Guo M; Wang R; Pan Y; Liu P; Zhang F; Guo C; Zhu F; Qu C; Ma C
Liver Int; 2015 Mar; 35(3):1087-94. PubMed ID: 25047684
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT.
Luan F; Liu H; Gao L; Liu J; Sun Z; Ju Y; Hou N; Guo C; Liang X; Zhang L; Sun W; Ma C
Gut; 2009 Nov; 58(11):1528-37. PubMed ID: 19651630
[TBL] [Abstract][Full Text] [Related]
3. HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma.
Liu P; Zhang H; Liang X; Ma H; Luan F; Wang B; Bai F; Gao L; Ma C
Oncotarget; 2015 Oct; 6(30):29048-59. PubMed ID: 26315112
[TBL] [Abstract][Full Text] [Related]
4. Correlation between HBV protein preS2 and tumor markers of hepatocellular carcinoma.
Luan F; Liu B; Zhang J; Cheng S; Zhang B; Wang Y
Pathol Res Pract; 2017 Sep; 213(9):1037-1042. PubMed ID: 28869105
[TBL] [Abstract][Full Text] [Related]
5. In vitro transfection of the hepatitis B virus PreS2 gene into the human hepatocarcinoma cell line HepG2 induces upregulation of human telomerase reverse transcriptase.
Liu H; Luan F; Ju Y; Shen H; Gao L; Wang X; Liu S; Zhang L; Sun W; Ma C
Biochem Biophys Res Commun; 2007 Apr; 355(2):379-84. PubMed ID: 17307151
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma.
Tang S; Hu W; Hu J; Wu S; Li J; Luo Y; Cao M; Zhou H; Jiang X
Liver Int; 2015 Feb; 35(2):608-19. PubMed ID: 24423280
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus PreS2-mutant large surface antigen activates store-operated calcium entry and promotes chromosome instability.
Yen TT; Yang A; Chiu WT; Li TN; Wang LH; Wu YH; Wang HC; Chen L; Wang WC; Huang W; Chang CW; Chang MD; Shen MR; Su IJ; Wang LH
Oncotarget; 2016 Apr; 7(17):23346-60. PubMed ID: 26992221
[TBL] [Abstract][Full Text] [Related]
8. The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways.
Hildt E; Hofschneider PH
Recent Results Cancer Res; 1998; 154():315-29. PubMed ID: 10027012
[TBL] [Abstract][Full Text] [Related]
9. Blockade of preS2 down-regulates the apoptosis of HepG2.2.15 cells induced by TRAIL.
Liang X; Qu Z; Zhang Z; Du J; Liu Y; Cui M; Liu H; Gao L; Han L; Liu S; Cao L; Zhao P; Sun W
Biochem Biophys Res Commun; 2008 May; 369(2):456-63. PubMed ID: 18284918
[TBL] [Abstract][Full Text] [Related]
10. Creation of a six-fingered artificial transcription factor that represses the hepatitis B virus HBx gene integrated into a human hepatocellular carcinoma cell line.
Zhao X; Zhao Z; Guo J; Huang P; Zhu X; Zhou X; Yang Z; Zhao L; Xu L; Xu J; Fu L; Zhang J; Zhang X; Dong Y; Huang G; Wang Q; Li B; Song X; Yang X; Liu S; Yi S; Yu T; Yu C; Hou L; Li J; Chen W
J Biomol Screen; 2013 Apr; 18(4):378-87. PubMed ID: 23042077
[TBL] [Abstract][Full Text] [Related]
11. [Effects of PreS2 synthetic peptides on infiltrating T lymphocyte subgroups expression in hepatocellular carcinoma].
Zheng SC; Wei XY; Xu CB; Xie HQ
Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):415-7. PubMed ID: 12890345
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.
Hsieh YH; Su IJ; Yen CJ; Tsai TF; Tsai HW; Tsai HN; Huang YJ; Chen YY; Ai YL; Kao LY; Hsieh WC; Wu HC; Huang W
Carcinogenesis; 2013 Feb; 34(2):475-85. PubMed ID: 23172669
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.
Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H
Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422
[TBL] [Abstract][Full Text] [Related]
15. Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases.
Raimondo G; Costantino L; Caccamo G; Pollicino T; Squadrito G; Cacciola I; Brancatelli S
J Hepatol; 2004 Mar; 40(3):515-9. PubMed ID: 15123368
[TBL] [Abstract][Full Text] [Related]
16. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator.
Kekulé AS; Lauer U; Meyer M; Caselmann WH; Hofschneider PH; Koshy R
Nature; 1990 Feb; 343(6257):457-61. PubMed ID: 2153938
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z
Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496
[TBL] [Abstract][Full Text] [Related]
19. HBx triggers either cellular senescence or cell proliferation depending on cellular phenotype.
Idrissi ME; Hachem H; Koering C; Merle P; Thénoz M; Mortreux F; Wattel E
J Viral Hepat; 2016 Feb; 23(2):130-8. PubMed ID: 26316075
[TBL] [Abstract][Full Text] [Related]
20. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
